Skip to content
10-Q

Quarterly Report

MBX Biosciences, Inc. MBX

0001193125-26-210593

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 47.6M sh
Shares Diluted Q1 2026 · Mar 31, 2026 46.58M sh
Shares Diluted Q1 2026 · Mar 31, 2025 33.41M sh
Capex Q1 2026 · Mar 31, 2026 $437K
Capex Q1 2026 · Mar 31, 2025 $30K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$20.21M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$22.68M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $45.21M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $75.29M
Stockholders Equity Q1 2026 · Mar 31, 2026 $437.76M
Stockholders Equity Q1 2026 · Dec 31, 2025 $369.22M
Stockholders Equity Q1 2026 · Mar 31, 2025 $235.42M
Stockholders Equity Q1 2026 · Dec 31, 2024 $257.44M
Current Liabilities Q1 2026 · Mar 31, 2026 $14.57M
Current Liabilities Q1 2026 · Dec 31, 2025 $15.5M
Total Liabilities Q1 2026 · Mar 31, 2026 $14.95M
Total Liabilities Q1 2026 · Dec 31, 2025 $15.92M
Current Assets Q1 2026 · Mar 31, 2026 $448.54M
Current Assets Q1 2026 · Dec 31, 2025 $381.54M
Total Assets Q1 2026 · Mar 31, 2026 $452.7M
Total Assets Q1 2026 · Dec 31, 2025 $385.14M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.50
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.71
Eps Basic Q1 2026 · Mar 31, 2026 −$0.50
Eps Basic Q1 2026 · Mar 31, 2025 −$0.71
Sga Expense Q1 2026 · Mar 31, 2026 $8.79M
Sga Expense Q1 2026 · Mar 31, 2025 $4.12M
Rd Expense Q1 2026 · Mar 31, 2026 $18.47M
Rd Expense Q1 2026 · Mar 31, 2025 $22.41M
Net Income Q1 2026 · Mar 31, 2026 −$23.52M
Net Income Q1 2026 · Dec 31, 2025 −$87M
Net Income Q1 2026 · Mar 31, 2025 −$23.88M
Operating Income Q1 2026 · Mar 31, 2026 −$27.27M
Operating Income Q1 2026 · Mar 31, 2025 −$26.53M